Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (751-760 of 1,132) with videos related to

Pageof 114
Sort By:
The Prostate|April 29, 2016
Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsiesLeander Van Neste, Alan W Partin, Grant D Stewart, et al.
The American Journal of Surgical Pathology|April 26, 2012
Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?Hillary M Ross, Oleksandr N Kryvenko, Janet E Cowan, et al.
Journal of Neurosurgery|March 1, 1995
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomasK D Judy, A Olivi, K G Buahin, et al.
Bulletin of Experimental Biology and Medicine|January 16, 2009
Study of bipathic effect of haloperidolT A Voronina, M V Belopolskaya, I A Kheyfets, et al.
The American Journal of Surgical Pathology|May 14, 2010
PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tractRoula Albadine, Luciana Schultz, Peter Illei, et al.
The American Journal of Surgical Pathology|August 6, 2009
Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfallsFabio Tavora, Daniel A Fajardo, Thomas K Lee, et al.
The American Journal of Pathology|May 1, 1996
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancersM Krajewska, S Krajewski, J I Epstein, et al.
Progress in Clinical and Biological Research|January 1, 1989
The value of prostate-specific antigen in the management of localized prostatic cancerP C Walsh, J E Oesterling, J I Epstein, et al.
American Journal of Clinical Pathology|October 1, 1986
Localized herpes simplex lymphadenitisJ I Epstein, R F Ambinder, F P Kuhajda, et al.
Urology|August 28, 2012
Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomyJeong S Han, Adam D Toll, Ali Amin, et al.
Pageof 114

Showing results (751-760 of 1,132) with videos related to

Sort By:
Pageof 114
The Prostate|April 29, 2016
Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsiesLeander Van Neste, Alan W Partin, Grant D Stewart, et al.
The American Journal of Surgical Pathology|April 26, 2012
Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?Hillary M Ross, Oleksandr N Kryvenko, Janet E Cowan, et al.
Journal of Neurosurgery|March 1, 1995
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomasK D Judy, A Olivi, K G Buahin, et al.
Bulletin of Experimental Biology and Medicine|January 16, 2009
Study of bipathic effect of haloperidolT A Voronina, M V Belopolskaya, I A Kheyfets, et al.
The American Journal of Surgical Pathology|May 14, 2010
PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tractRoula Albadine, Luciana Schultz, Peter Illei, et al.
The American Journal of Surgical Pathology|August 6, 2009
Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfallsFabio Tavora, Daniel A Fajardo, Thomas K Lee, et al.
The American Journal of Pathology|May 1, 1996
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancersM Krajewska, S Krajewski, J I Epstein, et al.
Progress in Clinical and Biological Research|January 1, 1989
The value of prostate-specific antigen in the management of localized prostatic cancerP C Walsh, J E Oesterling, J I Epstein, et al.
American Journal of Clinical Pathology|October 1, 1986
Localized herpes simplex lymphadenitisJ I Epstein, R F Ambinder, F P Kuhajda, et al.
Urology|August 28, 2012
Low prostate-specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant prostate cancer at radical prostatectomyJeong S Han, Adam D Toll, Ali Amin, et al.
Pageof 114